Phosphorylated Tau Interacts with c-Jun N-terminal Kinase-interacting Protein 1 (JIP1) in Alzheimer Disease

被引:134
作者
Ittner, Lars M. [1 ]
Ke, Yazi D. [1 ]
Goetz, Juergen
机构
[1] Univ Sydney, Brain & Mind Res Inst, Alzheimers & Parkinsons Dis Lab, Camperdown, NSW 2050, Australia
基金
澳大利亚研究理事会; 英国医学研究理事会;
关键词
AXONAL-TRANSPORT; SCAFFOLD PROTEIN; NEUROFIBRILLARY TANGLES; KINESIN; JNK; BINDING; BRAIN; OVEREXPRESSION; MICROTUBULES; AXONOPATHY;
D O I
10.1074/jbc.M109.014472
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In Alzheimer disease (AD) and frontotemporal dementia the microtubule-associated protein Tau becomes progressively hyperphosphorylated, eventually forming aggregates. However, how Tau dysfunction is associated with functional impairment is only partly understood, especially at early stages when Tau is mislocalized but has not yet formed aggregates. Impaired axonal transport has been proposed as a potential pathomechanism, based on cellular Tau models and Tau transgenic mice. We recently reported K369I mutant Tau transgenic K3 mice with axonal transport defects that suggested a cargo-selective impairment of kinesin-driven anterograde transport by Tau. Here, we show that kinesin motor complex formation is disturbed in the K3 mice. We show that under pathological conditions hyperphosphorylated Tau interacts with c-Jun N-terminal kinase-interacting protein 1 (JIP1), which is associated with the kinesin motor protein complex. As a result, transport of JIP1 into the axon is impaired, causing JIP1 to accumulate in the cell body. Because we found trapping of JIP1 and a pathological Tau/JIP1 interaction also in AD brain, this may have pathomechanistic implications in diseases with a Tau pathology. This is supported by JIP1 sequestration in the cell body of Tau-transfected primary neuronal cultures. The pathological Tau/JIP1 interaction requires phosphorylation of Tau, and Tau competes with the physiological binding of JIP1 to kinesin light chain. Because JIP1 is involved in regulating cargo binding to kinesin motors, our findings may, at least in part, explain how hyperphosphorylated Tau mediates impaired axonal transport in AD and frontotemporal dementia.
引用
收藏
页码:20909 / 20916
页数:8
相关论文
共 50 条
[1]   Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules [J].
Alonso, AD ;
GrundkeIqbal, I ;
Iqbal, K .
NATURE MEDICINE, 1996, 2 (07) :783-787
[2]   Neuronal microtubules: when the MAP is the roadblock [J].
Baas, PW ;
Qiang, L .
TRENDS IN CELL BIOLOGY, 2005, 15 (04) :183-187
[3]   Two binding partners cooperate to activate the molecular motor Kinesin-1 [J].
Blasius, T. Lynne ;
Cai, Dawen ;
Jih, Gloria T. ;
Toret, Christopher P. ;
Verhey, Kristen J. .
JOURNAL OF CELL BIOLOGY, 2007, 176 (01) :11-17
[4]   Kinesin-dependent axonal transport is mediated by the Sunday driver (SYD) protein [J].
Bowman, AB ;
Kamal, A ;
Ritchings, BW ;
Philp, AV ;
McGrail, M ;
Gindhart, JG ;
Goldstein, LSB .
CELL, 2000, 103 (04) :583-594
[5]   A NOVEL BRAIN ATPASE WITH PROPERTIES EXPECTED FOR THE FAST AXONAL-TRANSPORT MOTOR [J].
BRADY, ST .
NATURE, 1985, 317 (6032) :73-75
[6]   Posttranslational modifications of tau -: Role in human tauopathies and modeling in transgenic animals [J].
Chen, F ;
David, D ;
Ferrari, A ;
Götz, J .
CURRENT DRUG TARGETS, 2004, 5 (06) :503-515
[7]   Loss of progranulin function in frontotemporal lobar degeneration [J].
Cruts, Marc ;
Van Broeckhoven, Christine .
TRENDS IN GENETICS, 2008, 24 (04) :186-194
[8]   Phosphorylation of tau regulates its axonal transport by controlling its binding to kinesin [J].
Cuchillo-Ibanez, Inmaculada ;
Seereeram, Anjan ;
Byers, Helen L. ;
Leung, Kit-Yi ;
Ward, Malcolm A. ;
Anderton, Brian H. ;
Hanger, Diane P. .
FASEB JOURNAL, 2008, 22 (09) :3186-3195
[9]   Proteomic and functional analyses reveal a mitochondrial dysfunction in P301L Tau transgenic mice [J].
David, DC ;
Hauptmann, S ;
Scherping, I ;
Schuessel, K ;
Keil, U ;
Rizzu, P ;
Ravid, R ;
Dröse, S ;
Brandt, U ;
Müller, WE ;
Eckert, A ;
Götz, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (25) :23802-23814
[10]   β-amyloid treatment of two complementary P301 L tau-expressing Alzheimer's disease models reveals similar deregulated cellular processes [J].
David, Della C. ;
Ittner, Lars M. ;
Gehrig, Peter ;
Nergenau, Denise ;
Shepherd, Claire ;
Halliday, Glenda ;
Goetz, Jurgen .
PROTEOMICS, 2006, 6 (24) :6566-6577